Julia Seitz

661 total citations
21 papers, 390 citations indexed

About

Julia Seitz is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Julia Seitz has authored 21 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Julia Seitz's work include Breast Cancer Treatment Studies (4 papers), Breast Lesions and Carcinomas (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Julia Seitz is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Breast Lesions and Carcinomas (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Julia Seitz collaborates with scholars based in Germany, France and Switzerland. Julia Seitz's co-authors include Andreas Schneeweiß, Katharina Smetanay, Frederik Marmé, Laurent Bedenne, Jean‐Luc Raoul, Carlo Fremd, Dirk Jäger, Marc Ychou, Laurent Mineur and Thierry Conroy and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Julia Seitz

19 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Seitz Germany 9 247 103 74 70 61 21 390
Hiroshi Hirakawa Japan 9 60 0.2× 87 0.8× 124 1.7× 89 1.3× 30 0.5× 26 393
Dan Ferariu Romania 8 288 1.2× 88 0.9× 145 2.0× 29 0.4× 64 1.0× 51 499
Shung‐Haur Yang Taiwan 10 136 0.6× 81 0.8× 85 1.1× 32 0.5× 35 0.6× 17 274
Yuka Oku Japan 11 132 0.5× 45 0.4× 103 1.4× 19 0.3× 28 0.5× 28 406
Kouichiro Tsugawa Japan 10 196 0.8× 173 1.7× 214 2.9× 59 0.8× 61 1.0× 19 476
François‐Régis Ferrand France 11 211 0.9× 96 0.9× 143 1.9× 84 1.2× 34 0.6× 35 414
Koji Minami Japan 10 128 0.5× 75 0.7× 108 1.5× 69 1.0× 15 0.2× 38 378
Zhengyin Liao China 12 104 0.4× 84 0.8× 76 1.0× 70 1.0× 64 1.0× 26 389
Benoît Usunier France 6 70 0.3× 38 0.4× 102 1.4× 39 0.6× 10 0.2× 7 311
M. Langhi Argentina 8 273 1.1× 79 0.8× 46 0.6× 91 1.3× 25 0.4× 12 377

Countries citing papers authored by Julia Seitz

Since Specialization
Citations

This map shows the geographic impact of Julia Seitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Seitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Seitz more than expected).

Fields of papers citing papers by Julia Seitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Seitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Seitz. The network helps show where Julia Seitz may publish in the future.

Co-authorship network of co-authors of Julia Seitz

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Seitz. A scholar is included among the top collaborators of Julia Seitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Seitz. Julia Seitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seitz, Julia & Janina Fels. (2025). Activity-based acoustic situations in primary schools: Analyzing classroom noise and listening effort. The Journal of the Acoustical Society of America. 157(3). 1772–1783.
2.
Seitz, Julia, et al.. (2024). Listening effort in children and adults in classroom noise. Scientific Reports. 14(1). 25200–25200. 2 indexed citations
3.
Michel, Laura L., Justo Lorenzo Bermejo, Alexandra von Au, et al.. (2019). Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index. PLoS ONE. 14(1). e0211337–e0211337. 4 indexed citations
4.
Michel, Laura L., Justo Lorenzo Bermejo, Alexandra von Au, et al.. (2019). Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score. Breast Cancer Research and Treatment. 177(2). 437–446. 6 indexed citations
5.
Michel, Laura L., J Lorenzo Bermejo, Alexandra von Au, et al.. (2019). Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS+EG score. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 1 indexed citations
6.
Marmé, Frederik, Felix Hilpert, Manfred Welslau, et al.. (2019). Results of the second interim analysis of C-PATROL: A non-interventional study on olaparib within German routine clinical practice. Gynecologic Oncology. 154. 250–251. 1 indexed citations
7.
Sehouli, Jalid, Felix Hilpert, Manfred Welslau, et al.. (2019). Results of the 3rd interim analysis of C-Patrol: A non-interventional study on olaparib in German routine clinical practice. Annals of Oncology. 30. v412–v412. 1 indexed citations
8.
Seitz, Julia, et al.. (2019). Atezolizumab for use in PD-L1-positive unresectable, locally advanced or metastatic triple-negative breast cancer. Future Oncology. 16(3). 4439–4453. 54 indexed citations
9.
Smetanay, Katharina, Manuel Feißt, Julia Seitz, et al.. (2018). COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. Breast Cancer Research and Treatment. 173(1). 135–143. 38 indexed citations
10.
Sinn, Hans‐Peter, Andreas Schneeweiß, Marius Keller, et al.. (2017). Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer. BMC Cancer. 17(1). 124–124. 63 indexed citations
11.
Schneeweiß, Andreas, Julia Seitz, Katharina Smetanay, et al.. (2014). Efficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancer.. PubMed. 34(11). 6609–15. 27 indexed citations
12.
13.
Ychou, Marc, Jean‐Luc Raoul, Jean‐Yves Douillard, et al.. (2009). A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802). Annals of Oncology. 20(4). 674–680. 127 indexed citations
14.
Hammel, Pascal, F. Mornex, G. Deplanque, et al.. (2009). Oral tyrosine kinase inhibitor masitinib in combination with gemcitabine in patients with advanced pancreatic cancer: A multicenter phase II study. Journal of Clinical Oncology. 27(15_suppl). 4617–4617. 8 indexed citations
15.
Mitry, Emmanuel, Laëtitia Dahan, Marc Ychou, et al.. (2008). LV5FU2-cisplatin followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: Preliminary results of a randomized phase III trial (FFCD 0301). Journal of Clinical Oncology. 26(15_suppl). 4513–4513. 5 indexed citations
16.
Sherman, Morris, Vincenzo Mazzaferro, D. Amadori, et al.. (2008). Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and vascular invasion or extrahepatic spread: A subanalysis from the SHARP trial. Journal of Clinical Oncology. 26(15_suppl). 4584–4584. 20 indexed citations
17.
Raoul, Jean‐Luc, O. Bouché, Marco Giovannini, et al.. (2003). 46 Randomized phase II trial of LV5FU2, LV5FU2-cisplatinum or LV5FU2-irinotecan in patients (pts) with metastatic gastric or cardial adenocarcinoma (MGA): final results of study FFCD 9803. European Journal of Cancer Supplements. 1(5). S18–S18. 11 indexed citations
18.
Bedenne, Laurent, Julia Seitz, C Milan, et al.. (1998). [Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study].. PubMed. 22(3). 273–81. 18 indexed citations
19.
Thomas, P., R Giudicelli, Hervé Perrier, et al.. (1996). [Surgical treatment of esophageal cancer in patients over 70 years of age].. PubMed. 121(2). 101–7. 2 indexed citations
20.
Favre, R., et al.. (1983). [Prediction of response to antineoplastic agents].. PubMed. 12(45). 2875–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroshi Hirakawa Breakdown of academic impact, for papers by Dan Ferariu Breakdown of academic impact, for papers by Shung‐Haur Yang Breakdown of academic impact, for papers by Yuka Oku Breakdown of academic impact, for papers by Kouichiro Tsugawa Breakdown of academic impact, for papers by François‐Régis Ferrand Breakdown of academic impact, for papers by Koji Minami Breakdown of academic impact, for papers by Zhengyin Liao Breakdown of academic impact, for papers by Benoît Usunier Breakdown of academic impact, for papers by M. Langhi
Rankless by CCL
2026